The Panel Discussion on Monday has been changed and is now composed of:

• Prof. Bernardo Almada-Lobo (chair), Associate Professor at Faculdade de Engenharia da Universidade do Porto and Director of the INESC-TEC - Centre for Industrial Engineering and Management of the Associate Laboratory;
• Prof. Carlos Moreira (moderator), Comissão de Avaliação de Medicamentos (Committee for Drug and Medicines Evaluation) and INFARMED - Autoridade Nacional do Medicamento e Produtos de Saúde, IP (National Authority of Medicines and Health Products), Portugal;
• Prof. João Carvalho das Neves, CEO of ACSS, IP - Administração Central do Sistema de Saúde (Central Administration of the Health System) and ISEG - Instituto Superior de Economia e Gestão (Lisboa School of Economics and Management) - Universidade de Lisboa, Portugal;
• Dr. Rui Portugal, Director of the National Health Plan on behalf of Dr. Francisco George, Director-General of Health;
• Dr. Luís Cunha Ribeiro, President of the Conselho Diretivo da Administração Regional de Saúde de Lisboa e Vale do Tejo, IP (Directive Board of the Regional Health Authority of Lisbon and Tagus Valley).